U.S. Products
All product information provided is intended for U.S. healthcare professionals only. If you are not a healthcare professional and would like more information about any of these products, please contact your doctor. These products may not be available in countries outside the U.S. or may be available under a different trademark; in different strengths; or for different indications. Countries outside the U.S. may have different regulatory requirements that would call for different information to be available.
For an overview of Elan's research and development program, please click here.
For more information about Elan's pipeline and products, please click here.
Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding PRIALT® (ziconitide intrathecal infusion), please contact Azur Pharma at 1-888-PRI-ALT1 or by e-mail at MedicalAffairs@azurpharma.com
Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding MAXIPIME® (cefepime hydrochloride, USP) for Injection or AZACTAM® (aztreonam for injection, USP), please contact Bristol Myers Squibb Medical Information (BMS) at 1-800-321-1335 or by email at Drug.Information@bms.com.
U.S. Products
Elan has a Patient Assistance Program to provide TYSABRI to patients who might not otherwise be able to afford it. For more information on Elan's Medical Needs Program, please contact 1-888-489-7227.
TYSABRI is a registered trademark of Elan Pharmaceuticals, Inc. in the United States and of Elan Pharma International Ltd. in various countries outside the United States.